Introduction
Bronchial asthma is a chronic inflammatory condition often complicated by psychiatric comorbidities. Clinical evidence suggests that asthmatic patients face a significantly higher risk of anxiety and depression compared to the general population. This relationship often forms a detrimental cycle: psychological distress can trigger asthma exacerbations, while poor asthma control further exacerbates mental health issues.
While the link is well-documented, the underlying biological mechanisms remain unclear. This study investigates whether specific genetic variations (polymorphisms) in the serotonin transporter (5-HTT), brain-derived neurotrophic factor (BDNF), and neuropeptide S receptor 1 (NPSR1) genes—all known to influence both emotional regulation and respiratory health—serve as risk factors for these comorbidities.
Methodology
This cross-sectional study involved 143 asthmatic patients and 175 healthy controls of Han Chinese ethnicity recruited from Zhongda Hospital, Southeast University, China.
Clinical and Psychological Assessment
Mental health was quantified using the Hamilton Anxiety Rating Scale (HAMA) and the Hamilton Depression Rating Scale (HAMD). Physical disease severity was assessed via the Asthma Control Test (ACT).
Genotyping
DNA was extracted from peripheral blood samples. The researchers employed Polymerase Chain Reaction-Restriction Fragment Length Polymorphism (PCR-RFLP) and direct sequencing to identify specific Single Nucleotide Polymorphisms (SNPs), including 5-HTTLPR (5-HTT), rs6265 (BDNF), and rs324981 (NPSR1).
Statistical Analysis
Allele distributions were compared using Chi-square tests. Crucially, the Scheirer-Ray-Hare test was utilized to analyze the interactive effects of different genotypes on anxiety and depression scores, moving beyond single-gene analysis.
Results
The study revealed significant associations between genetic interactions and psychiatric status in asthmatic patients.
Prevalence and Clinical Impact
Within the asthmatic cohort, 34.3% suffered from anxiety and 8.4% exhibited signs of depression. Patients with these comorbidities scored significantly lower on the ACT (approximately 14-16 points) compared to those without (approximately 19-20 points), confirming the link between mental health and physical asthma control.
Genetic Interactions
- Anxiety: A significant interaction was found between the 5-HTT (LL) genotype and the BDNF (A+) allele, which markedly increased anxiety scores ($H=5.99, P=0.015$).
- Depression: The interaction between BDNF (A+, GG) and NPSR1 (AA, T+) was a significant predictor for increased depression scores ($H=4.22, P=0.04$). Notably, NPSR1 polymorphisms showed no significant association when analyzed in isolation, highlighting the importance of gene-gene interactions.
- Gender and Education: Female asthmatics were more prone to BDNF polymorphisms and anxiety. Additionally, higher education levels were negatively correlated with depression, likely due to better disease management and treatment adherence.
Discussion and Conclusion
The findings underscore that the risk of psychiatric comorbidities in asthma is driven by synergistic interactions between multiple genes rather than single genetic markers. The 5-HTT, BDNF, and NPSR1 pathways appear to converge, influencing the psychological well-being of asthmatic patients.
While the study is limited by a small depression subgroup and its cross-sectional design, it provides a foundation for future longitudinal research. Understanding these genetic vulnerabilities could lead to more personalized treatment strategies, where adjunctive psychiatric therapy is integrated into asthma management for genetically predisposed individuals to improve overall clinical outcomes.
Summary updated